Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Effectiveness of the VRS100 Robotic Console System in Percutaneous Coronary Interventions: A Multicenter, Randomised, Non-inferiority Trial (ESSENCE)

NCT06032572 is registered in ClinicalTrials.gov with Shenzhen Raysight Intelligent Medical Technology Co., Ltd. as lead sponsor.

NCT NCT06032572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06032572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Effectiveness of the VRS100 Robotic Console System in Percutaneous Coronary Interventions: A Multicenter, Randomised, Non-inferiority Trial (ESSENCE)
Lead sponsor
Shenzhen Raysight Intelligent Medical Technology Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
September 8, 2023
Completion date
August 1, 2024
Enrollment
204 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

arteriosclerosis, cardiovascular diseases, coronary artery disease, coronary disease, myocardial ischemia, vascular disease occlusive